Aldosterone and telomere length in white blood cells

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 60, Issue 12, 2005, Pages 1593-1596

  Benetos, Athanase ^a,c   Gardner, Jeffrey P ^b   Kimura, Masayuki ^b   Labat, Carlos ^a   Nzietchueng, Rosine ^a   Dousset, Brigitte ^a   Zannad, Faiez ^a   Lacolley, Patrick ^a   Aviv, Abraham ^b  

^a INSERM   (France)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CREATININE; DNA; POTASSIUM; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; AGING; ALDOSTERONE BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CREATININE BLOOD LEVEL; DNA DETERMINATION; HEART RATE; HUMAN; HUMAN CELL; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RESTRICTION FRAGMENT; STATISTICAL ANALYSIS; TELOMERE; UNIVARIATE ANALYSIS;

EID: 31344476770     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/60.12.1593     Document Type: Article

References (25)

1. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381-1487.
2. Granger DN, Vowinkel T, Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension. 2004;43:924-931.
3. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458-460.
4. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA. 1995;92:11190-11194.
5. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27:339-344.
6. Okuda K, Khan MY, Skurnick J, Kimura M, Aviv H, Aviv A. Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis. Atherosclerosis. 2000;152:391-398.
7. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet. 2001;358:472-473.
8. Benetos A, Okuda K, Lajemi M, et al. Telomere length as an indicator of biologic aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension. 2001;37(pt 2):381-385.
9. Benetos A, Gardner JP, Zureik M, et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension. 2004;43:182-185.
10. Gardner JP, Li S, Srinivasan SR, et al. Rise in insulin resistance is associated with telomere attrition. Circulation. 2005;111:2171-2177.
11. Pu Q, Neves MF, Virdis A, Touyz RM, Schiffrin E. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension. 2003;42:49-55.
12. Park YM, Park MY, Suh YL, Park JB. NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats. Biochem Biophys Res Commun. 2004;313:812-817.
13. Nishiyama A, Yao L, Nagai Y, et al. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension. 2004;24:841-848.
14. Keidar S, Kaplan M, Pavlotzky E, et al. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development. Circulation. 2004;109:2213-2220.
15. Vasan RS, Evans JC, Larson MG, et al. Serum aldosterone and incidence of hypertension in nonhypertensive persons. N Engl J Med. 2004;351:33-41.
16. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717.
17. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309.
18. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of aging. Nature. 2000;508:239-247.
19. Finch C, Crimmins EM. Inflammatory exposure and historical changes in human life-spans. Science. 2004;305:1736-1739.
20. Aviv A. telomeres and human aging: facts and fibs. Sci Aging Knowledge Environ. 2004;51:pe43.
21. Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res. 1992;26:671-677.
22. Lombes M, Oblin ME, Gasc JM, Baulieu EE, Farman N, Bonvalet JP. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res. 1992;71:503-510.
23. Takeda Y, Miyamori I, Yoneda T, et al. Production of aldosterone in isolated rat blood vessels. Hypertension. 1995;25:170-173.
24. Lacolley P, Safar M, Lucet B, Ledudal K, Labat C, Benetos A. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol. 2001;37:662-667.
25. Benetos A, Lacolley P, Safar M. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Res. 1997;17:1152-1156.